Drug Profile


Alternative Names: Orlipastat; R 212; RO 180647; Tetrahydrolipstatin; Xenical

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Anorectics; Lactones
  • Mechanism of Action Lipase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Obesity

Most Recent Events

  • 06 Dec 2012 Invida is now called Menarini Asia-Pacific
  • 09 Dec 2011 First generic equivalent available in the UK for obesity
  • 11 Nov 2011 Invida Group has been acquired by Menarini
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top